Three-Dimensional Printing Using a Maize Protein: Zein-Based Inks in Biomedical Applications

The use of three-dimensional (3D) printing for biomedical applications has expanded exponentially in recent years. However, the current portfolio of 3D printable inks is still limited. For instance, only few protein matrices have been explored as printing/bioprinting materials. Here, we introduce the use of zein, the primary constitutive protein in maize seeds, as a 3D printable material. Zein-based inks were prepared by dissolving commercial zein powder in ethanol with or without polyethylene glycol (PEG400) as a plasticizer. The rheological characteristics of our materials, studied during 21 days of aging/maturation, showed an increase in the apparent viscosity as a function of time in all formulations. The addition of PEG400 decreased the apparent viscosity. Inks with and without PEG400 and at different maturation times were tested for printability in a BioX bioprinter. We optimized the 3D printing parameters for each ink formulation in terms of extrusion pressure and linear printing velocity. Higher fidelity structures were obtained with inks that had maturation times of 10 to 14 days. We present different proof-of-concept experiments to demonstrate the versatility of the engineered zein inks for diverse biomedical applications. These include printing of complex and/or free-standing 3D structures, tablets for controlled drug release, and scaffolds for cell culture.

Automated summary

The use of zein as a 3D printable material for biomedical applications was introduced in this study. Rheological characteristics of zein-based inks were studied, showing an increase in apparent viscosity over time and a decrease with the addition of PEG400. Optimal 3D printing parameters were determined for different maturation times, resulting in higher fidelity structures. Proof-of-concept experiments demonstrated the versatility of engineered zein inks for various biomedical applications.